VYNE Therapeutics Inc. Share Price
VYNEVYNE Therapeutics Inc. Stock Performance
Open $0.57 | Prev. Close $0.57 | Circuit Range N/A |
Day Range $0.56 - $0.57 | Year Range $0.28 - $2.94 | Volume 4,436 |
Average Traded $0.57 |
VYNE Therapeutics Inc. Share Price Chart
About VYNE Therapeutics Inc.
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor in Phase 1b trial for the acute control and chronic management of immune-mediated inflammatory conditions. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
VYNE Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Feb-26 | $0.57 | $0.56 | +0.00% |
05-Feb-26 | $0.57 | $0.56 | -1.40% |
04-Feb-26 | $0.58 | $0.57 | +1.24% |
03-Feb-26 | $0.57 | $0.57 | -0.53% |
02-Feb-26 | $0.57 | $0.57 | +0.53% |
30-Jan-26 | $0.56 | $0.57 | +0.00% |
29-Jan-26 | $0.57 | $0.57 | -0.53% |
FAQs on VYNE Therapeutics Inc. Share Price
Can I buy VYNE Therapeutics Inc. shares in India?
What is the share price of VYNE Therapeutics Inc.?
What is the 5 year returns of VYNE Therapeutics Inc.?
What are the high & low stock price of VYNE Therapeutics Inc. today?
What is the 52-week high and low of VYNE Therapeutics Inc. stock?